secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2022-09-23T23:59:59+00:00
Accession:  0000917520-22-000044
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences enters separation agreement with former COO Glenn Coleman; $1.67M severance
--------------------------------------------------------------------------------

- COO position eliminated; separation effective Sept 23, 2022. Severance of $1,668,600 payable in monthly installments over 18 months.
- Coleman remains eligible for 2022 annual bonus based on performance goals, paid on normal senior executive schedule.
- Previously unvested stock options and restricted stock awards fully vest; options exercisable on original schedule through max expiration.
- Performance stock unit awards remain outstanding and eligible to vest upon achievement of performance conditions.
- Two-year non-compete and non-solicit covenants apply; non-disparagement clause included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/0000917520-22-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/iart-20220923.htm
  HTML page:      https://secwatch.observer/filing/0000917520-22-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer